Last update 10 Jun 2026

FWY003

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
FWY003
Target-
Action-
Mechanism-
Therapeutic Areas
Congenital DisordersEye Diseases
Active Indication
Age Related Macular DegenerationGeographic Atrophy
Inactive Indication-
Originator Organization
Novartis Pharma AG
Active Organization
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.Novartis Institutes for Biomedical Research, Inc.Novartis Institutes for Biomedical Research, Inc.Novartis Pharma AG
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with FWY003
NCT07441642
/ RecruitingPhase 2
A Randomized, Double Masked, Placebo-controlled, Multicenter, Dose-range Finding Study to Assess the Efficacy and Safety of FWY003 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
100 Clinical Results associated with FWY003
Login to view more data
100 Translational Medicine associated with FWY003
Login to view more data
100 Patents (Medical) associated with FWY003
Login to view more data
100 Deals associated with FWY003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Age Related Macular DegenerationPhase 2
United States
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
Australia
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
Bulgaria
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
Canada
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
Czechia
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
France
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
Germany
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
Hungary
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
Italy
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Age Related Macular DegenerationPhase 2
Poland
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
09 Mar 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free